1 |
Lin E, Panfil AR, Sandel G, Jain P. Novel perspectives on antisense transcription in HIV-1, HTLV-1, and HTLV-2. Front Microbiol 2022;13:1042761. [PMID: 36620051 DOI: 10.3389/fmicb.2022.1042761] [Reference Citation Analysis]
|
2 |
Grant-McAuley W, Laeyendecker O, Monaco D, Chen A, Hudelson SE, Klock E, Brookmeyer R, Morrison D, Piwowar-Manning E, Morrison CS, Hayes R, Ayles H, Bock P, Kosloff B, Shanaube K, Mandla N, van Deventer A, Ruczinski I, Kammers K, Larman HB, Eshleman SH. Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment. BMC Infect Dis 2022;22:838. [PMID: 36368950 DOI: 10.1186/s12879-022-07850-0] [Reference Citation Analysis]
|
3 |
Nakano K, Watanabe T. Tuning Rex rules HTLV-1 pathogenesis. Front Immunol 2022;13:959962. [DOI: 10.3389/fimmu.2022.959962] [Reference Citation Analysis]
|
4 |
Pavesi A, Romerio F. Extending the Coding Potential of Viral Genomes with Overlapping Antisense ORFs: A Case for the De Novo Creation of the Gene Encoding the Antisense Protein ASP of HIV-1. Viruses 2022;14:146. [PMID: 35062351 DOI: 10.3390/v14010146] [Reference Citation Analysis]
|
5 |
Miller RH, Zimmer A, Moutot G, Mesnard JM, Chazal N. Retroviral Antisense Transcripts and Genes: 33 Years after First Predicted, a Silent Retroviral Revolution? Viruses 2021;13:2221. [PMID: 34835027 DOI: 10.3390/v13112221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Krappinger JC, Bonstingl L, Pansy K, Sallinger K, Wreglesworth NI, Grinninger L, Deutsch A, El-Heliebi A, Kroneis T, Mcfarlane RJ, Sensen CW, Feichtinger J. Non-coding Natural Antisense Transcripts: Analysis and Application. J Biotechnol 2021:S0168-1656(21)00210-8. [PMID: 34371054 DOI: 10.1016/j.jbiotec.2021.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
7 |
Gholizadeh Z, Iqbal MS, Li R, Romerio F. The HIV-1 Antisense Gene ASP: The New Kid on the Block. Vaccines (Basel) 2021;9:513. [PMID: 34067514 DOI: 10.3390/vaccines9050513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|